Clinical trial

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

NCT01046422

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE2

Study timeline

Study start (unknown)2010-05-01Date precision: month

Registry last updated2015-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Type 2unresolved

Interventions

BMS-770767DRUG

PlaceboDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

TorontoOntario, Canada1 MontrealQuebec, Canada1 Las VegasNevada, United States1 WinnipegManitoba, Canada1 IncheonSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01046422 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.